Catastrophic epileptic encephalopathy of unclear etiology following a mild metabolic insult generally has a poor outcome. Here, we present 2 such unrelated individuals in whom wholeexome sequencing identified the same de novo recurrent mutation (c.1207C>T p.Arg403Cys) in the gene encoding the guanosine triphosphatase (GTPase) Dynamin-1 like Protein (DNM1L) (reference sequence NM_012062.4).
mtDNA depletion documented in fibroblasts (figure e-1C, iii) and the borderline low mtDNA content in skeletal muscle from patient 1 (table).
Discussion
In 2 patients, we identified a de novo dominant mutation in DMN1L, the same mutation having now been identified in 4 unrelated patients with refractory epilepsy. 3 Presentation features and investigation findings supported an underlying mitochondrial pathology. Altered mitochondrial dynamics are now a well-established cause of disease (see supplementary information for reference, links.lww.com/NXG/A63), and defective mitochondrial fission may both cause synaptic dysfunction 1 and impair responses to infection. 4 In mice, constitutive homozygous knockouts of Drp1 (the murine homolog of DNM1L) do not survive embryogenesis, while conditional ablation leads to developmental defects, both associated with abnormal mitochondrial fission. 5 Individuals heterozygous for DNM1L p.Arg403Cys display a milder phenotype, both in terms of mitochondrial structural and functional abnormalities and symptom severity.
Previously described cases similarly display several years of relatively normal development followed by severe, refractory epilepsy following a mild metabolic insult, vaccinations, or lowgrade fever, resulting in profound global developmental delay. 3 As in case 1, nonspecific thalamic hyperintensities were seen on MRI scans on the 2 previously reported probands with the p.Arg403Cys mutation.
3 Case 2 demonstrated diffuse cerebral volume atrophy. These changes are in keeping with previously reported nonspecific T2 MRI hyperintensities and cerebral or cerebellar atrophy seen in other mitochondrial disorders. It remains to be seen whether MEFS is part of the same clinical spectrum of other conditions associated with status epilepticus related to febrile illnesses, i.e., new-onset refractory status epilepticus or febrile illness-related epilepsy syndrome. 6 DNM1L is required for division of mitochondria and peroxisomes, interacting with receptor Mff and endoplasmic reticulum (ER) components. The missense mutation shared in figure e-1A , links.lww.com/NXG/A62). Furthermore, knockdown of the DNM1L ortholog Drp1 in mouse cells and its ligand Mff can each cause mtDNA depletion and mitochondrial dysfunction, 7 consistent with the borderline low mtDNA content and COX activity in skeletal muscle we demonstrated in case 1. This is likely due to increased mitophagic flux (figure e-1C, i).
Our findings suggest that DNM1L is implicated as a genetic contributor to MEFS. DNM1L p.Arg403Cys mutation screening could therefore be useful in patients with similar presentations and in identifying impaired mitochondrial fission causing synaptic dysfunction 1 and defective response to infection.
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